287: 2023 in review, CEO report cards, and a look at the year ahead
It's our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.
Create your
podcast in
minutes
It is Free